Archived Publications

Highlights | 2016 | 2015 | 2014 | 2013 | 2012 | Archived

Lung cancer in England: Information from the National Lung Cancer Audit (LUCADA). Rich AL, Tata LJ, Stanley RA, Free CM, Peake MD, Baldwin DR, Hubbard RB. Lung Cancer. 2011;72:16-22.

The distribution of lung cancer across sectors of society in the United Kingdom: A study using national primary care data. Iyen-Omofoman B, Hubbard RB, Smith CJ, Sparks E, Bradley E, Bourke A, Tata LJ. BMC Public Health. 2011 Nov 10;11(1):857.

How do patient and hospital features influence outcomes in small-cell lung cancer in England? Rich AL, Tata LJ, Free CM, Stanley RA, Peake MD, Baldwin DR, Hubbard RB. Br J Cancer. 2011 Sep 6;105(6):746-52. doi: 10.1038/bjc.2011.310. Epub 2011 Aug 9.

Analysis of the interaction of induction regimens with p-glycoprotein expression in patients with acute myeloid leukaemia: results from the MRC AML15 trial. Pallis M, Hills R, White P, Grundy M, Russell N, Burnett A. Blood Cancer J. 2011 Jun;1(6):e23.

Inequalities in outcomes for non-small cell lung cancer: the influence of clinical characteristics and features of the local lung cancer service. Rich AL, Tata LJ, Free CM, Stanley RA, Peake MD, Baldwin DR, Hubbard RB. Thorax. 2011 Dec;66(12):1078-84.

Epigenetic reprogramming of breast cancer cells with oocyte extracts. Allegrucci C, Rushton MD, Dixon JE, Sottile V, Shah M, Kumari R, Watson S, Alberio R, Johnson AD. Molecular Cancer 2011,10(1);7.

Cordycepin inhibits protein synthesis and cell adhesion through effects on signal transduction. Wong YY, Moon A, Duffin R, Barthet-Barateig A, Meijer HA, Clemens MJ, De Moor CH. J Biol Chem. 2010, 285, 2610-2621.

United Kingdom Lung Screen (UKLS) Nodule Management Protocol: Modelling of a Single Screen Randomised Controlled Trial of Low- Dose CT Screening for Lung Cancer. D R Baldwin, SW Duffy, NJ Wald, R Page, D M Hansell, J K Field. Thorax. 2011;66:308-313.

How do patient and hospital features influence outcomes in small-cell lung cancer in England? Rich AL, Tata LJ, Free CM, Stanley RA, Peake MD, Baldwin DR, Hubbard RB. British Journal of Cancer. 9 August 2011;doi:10.1038/bjc.2011.310.

CT screening for lung cancer in the UK: position statement by UKLS investigators following the NLST report. Field JK, Baldwin D, Brain K et al. Thorax. 2011;66:736-737.

Angiotensin converting enzyme inhibitors and hepatocellular carcinoma incidence in the General Practice Research Database. Walker AJ, West J, Grainge MJ, Card TR. Cancer Causes Control. 2011 Dec;22(12):1743-7. Epub 2011 Sep 11. PubMed PMID: 21909951.

The prognostic significance of lymphovascular invasion in invasive breast carcinoma. EA Rakha, SG Martin, AHS Lee, DAL Morgan, Pharoah PD, Z Hodi, D MacMillan and IO Ellis. (2011). Cancer 118(15):3670-80.

EarlyCDT-Lung: an Immuno-biomarker Test as an Aid to Early Detection of Lung Cancer. Lam S, Boyle P, Healey G, Maddison P, Peek L, Murray A, Chapman CJ, Allen J, Wood WC, Sewell HF, Robertson JFR. Cancer Prev Res; 2011 4(7); 1126–34.

Immuno-biomarkers in small cell lung cancer: Potential early clinical signals. Chapman CJ, Thorpe AJ, Murray A, Parsy-Kowalska C, Allen J, Stafford K, Chauhan A, Kite T, Robertson J. Clin. Cancer Res. 2011 17(6): 1474-1480.

Clinical Validation of an Autoantibody Test for Lung Cancer. Boyle P, Chapman CJ, Holdenrieder S, Murray A, Robertson C, Wood WC, Maddison P, Healey G, Fairley GH, Barnes AC, Robertson JF. Ann Oncol. 2011 Feb;22(2):383-9.

Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. Mahmoud SM, Paish EC, Powe DG, Macmillan RD, Grainge MJ, Lee AH, et al. J Clin Oncol. 2011 May 20;29(15):1949-55.

Folic acid and prevention of colorectal adenomas: a combined analysis of randomized clinical trials. Figueiredo JC, Mott LA, Giovannucci E, Wu K, Cole B, Grainge MJ, et al. Int J Cancer. 2011 Jul 1;129(1):192-203.

Bone marrow transplantation in AML, and socioeconomic class: a UK population-based cohort study. Bhayat F, Das-Gupta E, Hubbard R. BMC Cancer 2010, 10:514 doi:10.1186/1471-2407-10-514.

Lung cancer in England: Information from the National Lung Cancer Audit (LUCADA). Rich AL, Tata LJ, Stanley RA, Free CM, Peake MD, Baldwin DR, Hubbard RB. Lung Cancer 2010 Aug 3. [Epub ahead of print]

Technical validation of an autoantibody test for lung cancer. Murray A, Chapman, CJ, Healey G, Peek LJ, Parsons G, Baldwin D, Barnes A, Sewell HF, Fritsche HA, Robertson JF. Ann Oncol. 2010 21(8): 1687-93.

Cancer testis antigen vaccination affords long-term protection in a murine model of ovarian cancer. Maurizio CI, YU Y, Mirandola L, Jenkins MR, Chapman C, Cannon M, Cobos E, Kast WM. PloS one. 2010 5(5), e10471.

Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer. Maddison P, Thorpe A, Silcocks P, Robertson JFR, Chapman CJ. Lung Cancer. 2010 Dec;70(3):335-9.

Histological grading of breast cancer on needle core biopsy: the role of immunohistochemical assessment of proliferation. Kwok TC, Rakha EA, Lee AH, Grainge M, Green AR, Ellis IO, et al. Histopathology. 2010 Aug;57(2):212-9.

Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case-control study. Armstrong RG, West J, Card TR. Am J Gastroenterol. 2010 Jul;105(7):1604-9. Epub 2010 Jan 26. PubMed PMID: 20104215.

The antecedents of biliary cancer: a primary care case-control study in the United Kingdom. Grainge MJ, West J, Solaymani-Dodaran M, Aithal GP, Card TR. Br J Cancer. 2009 Jan 13;100(1):178-80.

Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status. Foulkes WD, Grainge MJ, Rakha EA, Green AR, Ellis IO. Breast Cancer Res Treat. 2009 Sep;117(1):199-204.

Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Elsheikh SE, Green AR, Rakha EA, Powe DG, Ahmed RA, Collins HM, et al. Cancer Res. 2009 May 1;69(9):3802-9.

The incidence of and mortality from leukaemias in the UK: a general population-based study. Bhayat F, Das-Gupta E, Smith C, McKeever T, Hubbard R. BMC Cancer 2009 Jul 26;9:252.

NSAID use and risk of leukaemia: a population-based case-control study. Bhayat F, Das-Gupta E, Smith C, Hubbard R. Pharmacoepidemiol Drug Saf. 2009;18:833-6 [Epub ahead of print].

Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials. Smeeth L, Douglas I, Hall AJ, Hubbard R, Evans S. Br J Clin Pharmacol. 2009 Jan;67(1):99-109. [Epub 2008 Nov 5].

Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. Cole BF, Logan RF, Halabi S, Benamouzig R, Sandler RS, Grainge MJ, et al. J Natl Cancer Inst. 2009 Feb 18;101(4):256-66.

Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes. Rakha EA, El-Sayed ME, Powe DG, Green AR, Habashy H, Grainge MJ, et al. Eur J Cancer. 2008 Jan;44(1):73-83.

Validation of THIN data for non-melanoma skin cancer. Meal A, Leonardi-Bee J, Smith C, Hubbard R, Bath-Hextall F. Qual Primary Care 2008;16:49-52.

Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. Rakha EA, El-Sayed ME, Lee AH, Elston CW, Grainge MJ, Hodi Z, et al. J Clin Oncol. 2008 Jul 1;26(19):3153-8.

Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Logan RF, Grainge MJ, Shepherd VC, Armitage NC, Muir KR. Gastroenterology. 2008 Jan;134(1):29-38.

Ornithine decarboxylase G316A genotype is prognostic for colorectal adenoma recurrence and predicts efficacy of aspirin chemoprevention. Hubner RA, Muir KR, Liu JF, Logan RF, Grainge MJ, Houlston RS. Clin Cancer Res. 2008 Apr 15;14(8):2303-9.

A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. Abd Hamid UM, Royle L, Saldova R, Radcliffe CM, Harvey DJ, Storr SJ, Pardo M, Antrobus R, Chapman CJ, Zitzmann N, Robertson JF, Dwek RA, Rudd PM. Glycobiology. 2008 18(12): 1105-18.

Lung cancer – can autoantibodies provide an aid to diagnosis? Woodard, KW, Chapman CJ. Expert Opin. Med. Diagn. 2008 2(8).

The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serum. Storr SJ, Royle L, Chapman CJ, Hamid UM, Robertson JF, Murray A, Dwek RA, Rudd PM. Glycobiology. 2008 18(6): 456-62.

Autoantibodies in Lung Cancer - possibilities for early detection and subsequent cure. Chapman CJ, Murray A, McElveen JE, Sahin U, Luxemburger U, Türeci O, Wiewrodt R, Barnes AC, Robertson JF. Thorax 2008; 63: 228233.

Dairy products, polymorphisms in the vitamin D receptor gene and colorectal adenoma recurrence. Hubner RA, Muir KR, Liu JF, Logan RF, Grainge MJ, Houlston RS. Int J Cancer. 2008 Aug 1;123(3):586-93.

CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome. Elsheikh S, Green AR, Aleskandarany MA, Grainge M, Paish CE, Lambros MB, et al. Breast Cancer Res Treat. 2008 May;109(2):325-35.

Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial. Hubner RA, Muir KR, Liu JF, Logan RF, Grainge MJ, Houlston RS. Int J Cancer. 2007 Nov 1;121(9):2001-4.

Two-step method to isolate target recombinant protein from co-purified bacterial contaminant SlyD after immobilised metal affinity chromatography. Parsy CB, Chapman CJ, Barnes AC, Robertson JFR, Murray A. J Chromatogr B Analyt Technol Biomed Life Sci. 2007; 853(1-2):314-319.

Serum EGFR and HER-2 Expression in Primary and Metastatic Breast Cancer. Asgeirsson KS, Agrawal A, Allen C, Hitch A, Ellis IO, Chapman CJ, Cheung KL, Robertson JFR. Breast Cancer Res. 2007 9(6). R75

Autoantibodies in breast cancer: their use as an aid to early diagnosis. Chapman C, Murray A, Chakrabarti J Thorpe A, Woolston C, Sahin U, Barnes A, Robertson J. Ann Oncol 2007; 18: 868-873.

The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. Le Jeune I, Gribbin J, West J, Smith C, Cullinan P, Hubbard R. Respiratory Medicine 2007;101:2534-40.

Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study. Bath-Hextall F, Leonardi-Bee J, Smith C, Meal A, Hubbard R. Int J Cancer 2007;121:2105-08.

Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study. Jackson H, Solaymani-Dodaran M, Card TR, Aithal GP, Logan R, West J. Hepatology. 2007 Oct;46(4):1131-7. PubMed PMID: 17685473.

FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis. Elbauomy Elsheikh S, Green AR, Lambros MB, Turner NC, Grainge MJ, Powe D, et al. Breast Cancer Res. 2007;9(2):R23.

Folate metabolism polymorphisms influence risk of colorectal adenoma recurrence. Hubner RA, Muir KR, Liu JF, Sellick GS, Logan RF, Grainge M, et al. Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1607-13.

Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrence. Hubner RA, Muir KR, Liu JF, Logan RF, Grainge M, Armitage N, et al. Clin Cancer Res. 2006 Nov 1;12(21):6585-9.

Use of autoantibodies in breast cancer screening and diagnosis. Storr SJ, Chakrabarti J, Barnes A, Murray A, Chapman CJ, Robertson JF. Expert Rev Anticancer Ther. 2006 6(8):1215-23.

Cervical human papillomavirus screening among older women. Grainge MJ, Seth R, Guo L, Neal KR, Coupland C, Vryenhoef P, et al. Emerg Infect Dis. 2005 Nov;11(11):1680-5.

Human papillomavirus infection in women who develop high-grade cervical intraepithelial neoplasia or cervical cancer: a case-control study in the UK. Grainge MJ, Seth R, Coupland C, Guo L, Rittman T, Vryenhoef P, et al. Br J Cancer. 2005 May 9;92(9):1794-9.

Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Card TR, West J, Holmes GK. Aliment Pharmacol Ther. 2004 Oct 1;20(7):769-75. PubMed PMID: 15379837.

Risk of extra-oesophageal malignancies and colorectal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Solaymani-Dodaran M, Logan RF, West J, Card T, Coupland C. Sc and J Gastroenterol. 2004 Jul;39(7):680-5. PubMed PMID: 15370691.

Malignancy and mortality in people with coeliac disease: population based cohort study. West J, Logan RF, Smith CJ, Hubbard RB, Card TR. BMJ. 2004 Sep 25;329(7468):716-9. Epub 2004 Jul 21. PubMed PMID: 15269095; PubMed Central PMCID: PMC518895.

Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Solaymani-Dodaran M, Logan RF, West J, Card T, Coupland C. Gut. 2004 Aug;53(8):1070-4. PubMed PMID: 15247170; PubMed Central PMCID: PMC1774141.

Malignancy and mortality in people with coeliac disease: A population based study. West J, Logan RFA, Smith C, Hubbard R, Card TR. Br Med J 2004;329:716-8.

Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial. Lund JN, Scholefield JH, Grainge MJ, Smith SJ, Mangham C, Armitage NC, et al. Gut. 2001 Jul;49(1):91-6.

Lung cancer and cryptogenic fibrosing alveolitis: A population based cohort study. Hubbard R, Venn A, Lewis S, Britton J. Am J Respir Crit Care Med; 2000;161:5-8.

The Distribution Of Lung Cancer Across Sectors Of Society In The United Kingdom: A Study Using National Primary Care Data. Iyen-Omofoman B, Hubbard RB, Smith CJ, Sparks E, Bradley E, Bourke A and Tata LJ, 2011. Bmc Public Health. 11(1), 857

How Do Patient And Hospital Features Influence Outcomes In Small-Cell Lung Cancer In England? Rich AL, Tata LJ, Free CM, Stanley RA, Peake MD, Baldwin DR and Hubbard RB, 2011. British Journal Of Cancer. 105(6), 746-52

Inequalities In Outcomes For Non-Small Cell Lung Cancer: The Influence Of Clinical Characteristics And Features Of The Local Lung Cancer Service. Rich AL, Tata LJ, Free CM, Stanley RA, Peake MD, Baldwin DR and Hubbard RB, 2011. Thorax. 66(12), 1078-84

Lung cancer in England: Information from the National Lung Cancer Audit (LUCADA). Rich, Anna L, Tata, Laila J, Stanley, Rosamund A, Free, Catherine M, Peake, Michael D, Baldwin, David R and Hubbard, Richard B, 2010. Lung cancer (Amsterdam, Netherlands).

Improving outcomes for people with skin tumours including melanoma: Evidence Update October. Williams HC, Bath-Hextall F, Dewar D, Kelly C, Lansbury L, Lear J, Newton-Bishop J and Schofield J. 2011. National Institute for Health and Clinical Excellence.

Rapid acquisition of Raman spectral maps through minimal sampling: applications in tissue imaging. Rowlands CJ, Varma S, Perkins W, Leach I, Williams H and Notingher I. 2011. J Biophotonics.

Lung cancer in England: Information from the National Lung Cancer Audit (LUCADA). Rich AL, Tata LJ, Stanley RA, Free CM, Peake MD, Baldwin DR, Hubbard RB. 2011. Lung Cancer 72:16-22.

United Kingdom Lung Screen (UKLS) Nodule Management Protocol: Modelling of a Single Screen Randomised Controlled Trial of Low- Dose CT Screening for Lung Cancer. Baldwin DR, Duffy SW, Wald NJ, Page R, Hansell DM, Field JK. 2011. Thorax 66:308-313.

How do patient and hospital features influence outcomes in small-cell lung cancer in England? Rich AL, Tata LJ, Free CM, Stanley RA, Peake MD, Baldwin DR and Hubbard RB. 2011. British Journal of Cancer doi:10.1038/bjc.2011.310.

CT screening for lung cancer in the UK: position statement by UKLS investigators following the NLST report. Field JK, Baldwin D, Brain K et al. 2011. Thorax 66:736-737.

Imaging in Lung Cancer: recent advances in PET-CT and screening. Baldwin DR. 2011. Thorax 66:275-6.
Guidelines on the Management of Lung Cancer – Summary of the Update. Baldwin DR. 2011. BMJ 342:d2110.

Maintaining integrity in the face of death: a grounded theory to explain the perspectives of people affected by lung cancer about the expression of wishes for end of life care. Horne, G., Seymour, J.E. and Payne, S. (2011) International Journal of Nursing Studies, 49(6):718-26.

Highlights | 2016 | 2015 | 2014 | 2013 | 2012 | Archived

Archived Publications

Legal information

Get social